Genomes2People
From HandWiki
Genomes2People (G2P) is a research program based at Mass General Brigham, Broad Institute, Ariadne Labs, and Harvard Medical School that conducts research on translational genomics, precision medicine, and health outcomes.[1] The program investigates the medical, behavioral, and economic impacts of integrating genomic information for adults and children into clinical care and public health.[2][3]
Founded by Robert C. Green in 2011, G2P has received over $70 million from the National Institutes of Health (NIH) and other partners[4] to support multiple large-scale studies and clinical trials.[5][6]
References
- ↑ "Genomes2People – Research In Translational Genomics and Health Outcomes" (in en-US). https://www.genomes2people.org/.
- ↑ "Keynote Presentation: The Path to Universal Newborn Sequencing". https://www.labroots.com/webinar/keynote-presentation-path-universal-newborn-sequencing?srsltid=AfmBOor3GziiXUYiIqhWGBdxSpfQCneYepd0KJVqqeK2P-jFTTAwkZ0q.
- ↑ "Screening study brings Sanford Health, Harvard together" (in en). https://news.sanfordhealth.org/news-release/screening-study-brings-sanford-health-harvard-together/.
- ↑ Borrelli-Persson, Laird (2020-12-22). "Franca Sozzani Has Inspired a Scientific Fund—And Now a Website" (in en-US). https://www.vogue.com/article/franca-sozzani-fund-website.
- ↑ Labs, Ariadne. "Ariadne Labs and Genomes2People Launch New Precision Population Health Initiative" (in en). https://www.prnewswire.com/news-releases/ariadne-labs-and-genomes2people-launch-new-precision-population-health-initiative-301253965.html.
- ↑ Wolf, Susan M.; Green, Robert C. (2023-08-25). "Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal". Annual Review of Genomics and Human Genetics 24: 393–414. doi:10.1146/annurev-genom-101122-103209. ISSN 1545-293X. PMID 36913714. PMC 10497726. https://pubmed.ncbi.nlm.nih.gov/36913714.
 |  |
